Trials / Unknown
UnknownNCT04234321
Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site
A Multicenter, Prospective Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this study is to observe whether basic fibroblast growth factor and Kangfuxin Liquid can promote the wound healing in the donor area and further evaluate the healing quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | basic fibroblast growth factor | Basic fibroblast growth factor,100ml/ bottle, (35000IU / 8ml) / 100cm2 / time,three times a day. |
| DRUG | Kangfuxin Liquid | Kangfuxin Liquid,20ml / 100cm2 / time,three times a day. |
| DRUG | 0.9% Normal saline | 0.9% Normal saline,20ml / 100cm2 / time,three times a day. |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2022-06-30
- Completion
- 2022-12-31
- First posted
- 2020-01-21
- Last updated
- 2020-05-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04234321. Inclusion in this directory is not an endorsement.